FI813034L - FRAMEWORK FOR IMPLEMENTATION OF IMMOVABLE SUBSTANCES - Google Patents

FRAMEWORK FOR IMPLEMENTATION OF IMMOVABLE SUBSTANCES

Info

Publication number
FI813034L
FI813034L FI813034A FI813034A FI813034L FI 813034 L FI813034 L FI 813034L FI 813034 A FI813034 A FI 813034A FI 813034 A FI813034 A FI 813034A FI 813034 L FI813034 L FI 813034L
Authority
FI
Finland
Prior art keywords
immovable
framework
substances
implementation
immovable substances
Prior art date
Application number
FI813034A
Other languages
Finnish (fi)
Other versions
FI77230C (en
FI77230B (en
Inventor
Michel Vincent
Georges Remond
Michel Laubie
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26222007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI813034(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR8021095A external-priority patent/FR2491469A1/en
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of FI813034L publication Critical patent/FI813034L/en
Application granted granted Critical
Publication of FI77230B publication Critical patent/FI77230B/en
Publication of FI77230C publication Critical patent/FI77230C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
FI813034A 1980-10-02 1981-09-30 FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE PERHYDROINDOLIMINODISYROR MED ANTIHYPERTENSIV AKTIVITET. FI77230C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8021095 1980-10-02
FR8021095A FR2491469A1 (en) 1980-10-02 1980-10-02 2-Carboxy-per:hydro-indole(s) and per or tetra:hydro-isoquinoline(s) - having a carboxy-substd. amino-acyl N-gp., inhibit carboxy:poly:peptidase(s), and kininase II and control hypertension
FR8106916A FR2503155A2 (en) 1980-10-02 1981-04-07 NOVEL SUBSTITUTED IMINO DIACIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
FR8106916 1981-04-07

Publications (3)

Publication Number Publication Date
FI813034L true FI813034L (en) 1982-04-03
FI77230B FI77230B (en) 1988-10-31
FI77230C FI77230C (en) 1989-02-10

Family

ID=26222007

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813034A FI77230C (en) 1980-10-02 1981-09-30 FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE PERHYDROINDOLIMINODISYROR MED ANTIHYPERTENSIV AKTIVITET.

Country Status (29)

Country Link
EP (1) EP0049658B1 (en)
JP (1) JPS5791974A (en)
KR (1) KR860001875B1 (en)
AR (1) AR242949A1 (en)
AT (1) ATE7910T1 (en)
AU (1) AU542611B2 (en)
CA (1) CA1341196C (en)
DD (1) DD201783A5 (en)
DE (1) DE3164201D1 (en)
DK (1) DK157011C (en)
EG (1) EG15361A (en)
ES (1) ES8305723A1 (en)
FI (1) FI77230C (en)
FR (1) FR2503155A2 (en)
GE (1) GEP19970943B (en)
GR (1) GR75016B (en)
HU (1) HU185147B (en)
IE (1) IE51821B1 (en)
IL (1) IL63940A (en)
LU (1) LU88262I2 (en)
MD (1) MD381C2 (en)
NL (1) NL930046I2 (en)
NO (1) NO160780C (en)
NZ (1) NZ198535A (en)
OA (1) OA06914A (en)
PH (1) PH17516A (en)
PT (1) PT73755B (en)
SU (1) SU1153827A3 (en)
UA (1) UA6308A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933361A (en) * 1981-12-29 1990-06-12 Hoechst Aktiengesellschaft Derivatives of bicyclic aminoacids agents containing these compounds and their use
US4977260A (en) * 1986-11-21 1990-12-11 Hoechst Aktiengesellschaft Intermediates for preparing mono-, bi- and tricyclic amino acids
US5011940A (en) * 1987-07-03 1991-04-30 Hoechst Aktiengesellschaft Process for the preparation of bicyclic amino carboxylic acids, intermediates in this process, and their use
US5053519A (en) * 1981-11-05 1991-10-01 Hoechst Ag Cis, endo-2-azabicyclo-[3.3.0]-octane-5-carboxylic acids
US5055591A (en) * 1983-09-16 1991-10-08 Hoechst Aktiengesellschaft Process for the preparation of octahydropenta(b)pyrrole carboxylates
US5068351A (en) * 1983-09-16 1991-11-26 Hoechst Aktiengesellschaft Process for the preparation of n octahydropenta (6) pyrrole carboxylates
US5098910A (en) * 1986-10-02 1992-03-24 Hoechst Aktiengesellschaft Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US5231080A (en) * 1985-10-15 1993-07-27 Hoechst Aktiengesellschaft Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
US5403856A (en) * 1984-04-12 1995-04-04 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors
US5550255A (en) * 1984-08-28 1996-08-27 Hoechst Aktiengesellschaft Cis, endo-2-azabicycloalkane-3-carboxylic acid derivatives
US5747504A (en) * 1984-04-12 1998-05-05 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0278530A3 (en) * 1980-08-30 1989-08-02 Hoechst Aktiengesellschaft Amino acid derivatives, process for their preparation, agents containing them and their use
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
EP0050800B2 (en) * 1980-10-23 1995-06-07 Schering Corporation Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
US4479963A (en) * 1981-02-17 1984-10-30 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
IN156096B (en) * 1981-03-19 1985-05-11 Usv Pharma Corp
EP0065301A1 (en) * 1981-05-18 1982-11-24 Merck & Co. Inc. Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same
SU1327787A3 (en) * 1981-11-05 1987-07-30 Хехст Аг (Фирма) Method of producing cis,endo-2-azabicyclo-(3,3,0)-octane-3-carboxylic acids or acid-additive salts thereof
EP0170775B2 (en) * 1981-12-29 1994-10-12 Hoechst Aktiengesellschaft Derivatives of bicyclic amino acids, processes for their preparation, agents containing them and their use as well as bicyclic amino acids as intermediates and process for their preparation
DE3210496A1 (en) * 1982-03-23 1983-10-06 Hoechst Ag NEW DERIVATIVES OF BICYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF, THE MEANS CONTAINING THEM AND THE USE THEREOF, AND NEW BICYCLIC AMINO ACIDS AS INTERMEDIATE STAGES AND METHOD FOR THE PRODUCTION THEREOF
DE3302125A1 (en) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
US5175306A (en) * 1983-01-31 1992-12-29 Hoechst Aktiengesellschaft Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters
HU191120B (en) * 1983-01-31 1987-01-28 Hoechts Ag,De Process for raceme separation of optically active byciclic imino-alpha-carbonic acid esthers
DE3303344A1 (en) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING N-ALKYLATED AMINO ACIDS AND THEIR ESTERS
DE3408923A1 (en) * 1984-03-12 1985-09-26 Hoechst Ag, 6230 Frankfurt CARBOXYALKYLDIPEPTIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THE AGENTS CONTAINING THEM AND THE USE THEREOF
GB8422165D0 (en) * 1984-09-01 1984-10-03 Wellcome Found Compounds
US4693996A (en) * 1985-12-23 1987-09-15 Warner-Lambert Company Method of treating heart failure and medicaments therefor
FR2620703B1 (en) * 1987-09-17 1991-10-04 Adir PROCESS FOR THE INDUSTRIAL SYNTHESIS OF PERHYDROINDOLE CARBOXYLIC ACID - 2 (2S, 3AS, 7AS). APPLICATION TO THE SYNTHESIS OF CARBOXYALKYL DIPEPTIDES
FR2620699B1 (en) * 1987-09-17 1990-06-01 Adir PROCESS FOR THE SYNTHESIS OF ALPHA AMINO N ALKYL ACIDS AND THEIR ESTERS. APPLICATION TO THE SYNTHESIS OF CARBOXYALKYL DIPEPTIDES
FR2620709B1 (en) * 1987-09-17 1990-09-07 Adir PROCESS FOR THE INDUSTRIAL SYNTHESIS OF PERINDOPRIL AND ITS MAIN INTERMEDIATE SYNTHESIS
FR2620700B1 (en) * 1987-09-17 1990-06-01 Adir PROCESS FOR THE SYNTHESIS OF ALPHA AMINO ACIDS N ALKYLS AND THEIR ESTERS. APPLICATION TO THE SYNTHESIS OF CARBOXYALKYL DIPEPTIDES
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
TW197945B (en) * 1990-11-27 1993-01-11 Hoechst Ag
LT3872B (en) 1993-12-06 1996-04-25 Hoechst Ag Novel peptides and pharmaceutical compositions containing them
FR2746394B1 (en) 1996-03-20 1998-05-29 Roussel Uclaf NOVEL TRICYCLIC COMPOUNDS, THEIR PREPARATION PROCESS, AND INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT796855E (en) 1996-03-20 2002-07-31 Hoechst Ag INHIBITION OF REABSORCAO IN BONES AND ANTAGONISTS OF VITRONECTIN
DE19653647A1 (en) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin receptor antagonists, their preparation and their use
DE19741873A1 (en) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh New 5-ring heterocycles, their preparation, their use and pharmaceutical preparations containing them
DE19751251A1 (en) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituted imidazolidine derivatives, their manufacture, their use and pharmaceutical preparations containing them
DE19821483A1 (en) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
FR2807431B1 (en) * 2000-04-06 2002-07-19 Adir NOVEL PROCESS FOR THE SYNTHESIS OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
FR2807430B1 (en) * 2000-04-11 2002-05-17 Adir NOVEL PROCESS FOR THE SYNTHESIS OF N - [(S) -1- CARBOXYBUTYL] - (S) -ALANINE ESTERS AND APPLICATION TO THE SYNTHESIS OF PERINDOPRIL
FR2811320B1 (en) * 2000-07-06 2002-08-23 Adir NOVEL ALPHA CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRIL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2811318B1 (en) * 2000-07-06 2002-08-23 Adir NOVEL GAMMA CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRIL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU2007203451B2 (en) * 2000-07-06 2010-09-02 Les Laboratoires Servier Pharmaceutical composition containing a crystalline form of perindopril tert-butylamine salt
FR2827860B1 (en) * 2001-07-24 2004-12-10 Servier Lab NOVEL PROCESS FOR SYNTHESIS OF ACID DERIVATIVES (2S, 3AS, 7AS) -1 - [(S) -ALANYL] -OCTAHYDRO-1H-INDOLE-2-CARBOXYLINE AND APPLICATION TO THE SYNTHESIS OF PERINDOPRIL
SI1333026T1 (en) * 2002-01-30 2007-10-31 Servier Lab Process for the preparation of high purity perindopril and intermediates useful in the synthesis
FR2838648B1 (en) * 2002-04-18 2004-05-21 Servier Lab NEW PERINDOPRIL SALT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
BRPI0411966A (en) 2003-06-24 2006-08-29 Servier Lab crystalline forms of perindopril erbumin
ATE315043T1 (en) * 2003-06-30 2006-02-15 Servier Lab METHOD FOR THE SYNTHESIS OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
ATE338766T1 (en) * 2003-08-29 2006-09-15 Servier Lab METHOD FOR THE SYNTHESIS OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
DK1362845T3 (en) * 2003-09-01 2010-01-18 Servier Lab New Process for the Production of Esters of N - ((S) -1-Carboxybutyl) - (S) -alanine and Their Use in the Preparation of Perindopril
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
GB2413128A (en) * 2004-04-13 2005-10-19 Neopharma Ltd Process for the preparation of perindopril
SI21800A (en) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto New procedure of synthesis of perindopril
SI21881A (en) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. New crystal forms of perindopril erbumine hydrates, procedure of their preparation and pharmaceutical forms containing these compounds
EP1987828A1 (en) 2005-01-06 2008-11-05 IPCA Laboratories Limited salts of perindopril and their use in the therapy of hypertension
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
FR2897866B1 (en) * 2006-02-28 2008-04-18 Servier Lab ALPHA CRYSTALLINE FORM OF PERINOPRIL ARGININE SALT, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
SI22543A (en) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto New salts of perindopril
GB0910692D0 (en) 2009-06-20 2009-08-05 Teva Pharma Compound
PT105315B (en) 2010-09-29 2013-01-16 Inst Superior Tecnico A NEW CRYSTALIN HYDRATE FORM OF PERINDOPRIL ERBUMINE, METHODS FOR PREPARATION AND USE IN PHARMACEUTICAL PREPARATIONS
FR2985511B1 (en) 2012-01-05 2014-01-03 Servier Lab CRYSTALLINE DELTA FORM OF PERINOPRIL ARGININE SALT, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2985512B1 (en) 2012-01-05 2014-06-20 Servier Lab PROCESS FOR THE PREPARATION OF L-ARGININE SALT OF PERINDOPRIL
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (en) 2016-04-20 2020-07-10 Les Laboratoires Servier PHARMACEUTICAL COMPOSITION COMPRISING A BETA-BLOCKER, A CONVERSION ENZYME INHIBITOR AND AN ANTIHYPERTENSOR OR NSAID.
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5572169A (en) * 1978-11-27 1980-05-30 Tanabe Seiyaku Co Ltd Isoquinoline derivative and its preparation
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
DE3063420D1 (en) * 1979-03-26 1983-07-07 Takeda Chemical Industries Ltd Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension
US4294832A (en) * 1979-04-28 1981-10-13 Tanabe Seiyaku Co., Ltd. Tetrahydroisoquinoline compounds and a pharmaceutical composition thereof
GB2048863B (en) * 1979-05-16 1983-06-15 Morton Norwich Products Inc Tetrahydroisoquinoline-3-carboxylic acids
US4303583A (en) * 1979-08-13 1981-12-01 American Home Products Corporation 1H,5H-[1,4]Thiazepino[4,3-a]indole-1,5-diones
FR2487829A2 (en) * 1979-12-07 1982-02-05 Science Union & Cie NOVEL SUBSTITUTED IMINO ACIDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
FR2470767A1 (en) * 1979-12-07 1981-06-12 Science Union & Cie N-Acyl-2-carboxy fused ring heterocyclic cpds. - useful for inhibiting angiotensin converting enzyme and enkephalin(s)
ZA811493B (en) * 1980-04-02 1982-03-31 Warner Lambert Co Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids
US4251444A (en) * 1980-04-07 1981-02-17 American Home Products Corporation Thiazepino-[4,3-b]-isoquinoline-1,5-dione derivatives and precursors
EP0278530A3 (en) * 1980-08-30 1989-08-02 Hoechst Aktiengesellschaft Amino acid derivatives, process for their preparation, agents containing them and their use
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053519A (en) * 1981-11-05 1991-10-01 Hoechst Ag Cis, endo-2-azabicyclo-[3.3.0]-octane-5-carboxylic acids
US5061722A (en) * 1981-11-05 1991-10-29 Hoechst Ag Cis, endo-2-azabicyclo-[3.3.0]-octane-3-carboxylic acids, a process for their preparation, agents containing these compounds and their use
US4933361A (en) * 1981-12-29 1990-06-12 Hoechst Aktiengesellschaft Derivatives of bicyclic aminoacids agents containing these compounds and their use
US5068351A (en) * 1983-09-16 1991-11-26 Hoechst Aktiengesellschaft Process for the preparation of n octahydropenta (6) pyrrole carboxylates
US5055591A (en) * 1983-09-16 1991-10-08 Hoechst Aktiengesellschaft Process for the preparation of octahydropenta(b)pyrrole carboxylates
US5403856A (en) * 1984-04-12 1995-04-04 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors
US5747504A (en) * 1984-04-12 1998-05-05 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors
US5550255A (en) * 1984-08-28 1996-08-27 Hoechst Aktiengesellschaft Cis, endo-2-azabicycloalkane-3-carboxylic acid derivatives
US5231080A (en) * 1985-10-15 1993-07-27 Hoechst Aktiengesellschaft Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US5098910A (en) * 1986-10-02 1992-03-24 Hoechst Aktiengesellschaft Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
US5500434A (en) * 1986-10-02 1996-03-19 Hoechst Aktiengesellschaft Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
US5721244A (en) * 1986-10-02 1998-02-24 Hoechst Aktiengesellschaft Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
US4977260A (en) * 1986-11-21 1990-12-11 Hoechst Aktiengesellschaft Intermediates for preparing mono-, bi- and tricyclic amino acids
US5011940A (en) * 1987-07-03 1991-04-30 Hoechst Aktiengesellschaft Process for the preparation of bicyclic amino carboxylic acids, intermediates in this process, and their use

Also Published As

Publication number Publication date
FR2503155A2 (en) 1982-10-08
AU542611B2 (en) 1985-02-28
FR2503155B2 (en) 1983-07-01
FI77230C (en) 1989-02-10
NZ198535A (en) 1984-09-28
NL930046I2 (en) 1994-01-03
IL63940A (en) 1985-06-30
ES505999A0 (en) 1983-04-16
NO160780C (en) 1989-05-31
IE812257L (en) 1983-03-29
NL930046I1 (en) 1993-09-01
EP0049658A1 (en) 1982-04-14
OA06914A (en) 1983-05-31
KR830007564A (en) 1983-10-21
PT73755A (en) 1981-11-01
JPS5791974A (en) 1982-06-08
JPH0132239B2 (en) 1989-06-29
KR860001875B1 (en) 1986-10-24
AU7594981A (en) 1982-04-08
UA6308A1 (en) 1994-12-29
ES8305723A1 (en) 1983-04-16
DK434381A (en) 1982-04-03
AR242949A1 (en) 1993-06-30
GEP19970943B (en) 1997-04-18
DE3164201D1 (en) 1984-07-19
CA1341196C (en) 2001-03-06
EG15361A (en) 1987-04-30
HU185147B (en) 1984-12-28
PH17516A (en) 1984-09-13
IL63940A0 (en) 1981-12-31
NO160780B (en) 1989-02-20
DD201783A5 (en) 1983-08-10
FI77230B (en) 1988-10-31
EP0049658B1 (en) 1984-06-13
GR75016B (en) 1984-07-12
PT73755B (en) 1983-10-11
ATE7910T1 (en) 1984-06-15
IE51821B1 (en) 1987-04-01
NO813339L (en) 1982-04-05
DK157011B (en) 1989-10-30
SU1153827A3 (en) 1985-04-30
LU88262I2 (en) 1994-02-03
DK157011C (en) 1990-03-26
MD381C2 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
FI813034L (en) FRAMEWORK FOR IMPLEMENTATION OF IMMOVABLE SUBSTANCES
FI813531L (en) FRAMEWORK FOR THE FRAMEWORK OF ENCLOSURES
NO843718L (en) PROCEDURE FOR DIVOLUTION OF DOUBLE-TREED DNA
FI813505L (en) PROCEDURE FOR THE PURPOSE OF AOTERVATION AV LOESNINGSMEDEL
FI812920L (en) PULVERFORMED SAFETY ORGANIZATION FOR THE FRAMEWORK OF FRAMEWORK
FI813279L (en) FRAMEWORK FOR THE FRAMEWORK OF AZABICYCLO-OCTAN-CARBOLXYLSYROR
FI823556L (en) FRAMEWORK FOR HYDROXIPROPYLSTAERKELSE
FI822857L (en) FRAMEWORK FOR THE FRAMEWORK OF FRAMSTAELLNING AV EN FAERGKILFOLIE
FI822747A0 (en) FRAMEWORK FOR PYRIDAZINAMINFOERENINGAR
FI810570L (en) FRAMEWORK FOR THE FRAMEWORK OF GRAPHICS
FI811197L (en) ANORDINATION OF FASTSAETTNING AV EN SKIDSKO VID EN SKIDA
FI831148A0 (en) PROCEDURE FOR THE FRAMEWORK OF SUBSTANCES
FI811176L (en) FREQUENCY REQUIREMENT FOR FLUORING
FI821311L (en) FRAMEWORK FOR ORGANIZATION OF ORGANIC DITIOSYROR OCH DERAS ANVAENDNING
FI823671L (en) FRAMEWORK FRAMEWORK FOR ENCLOSURE
FI812240L (en) MASSUPPLOESARE FOR FRAMSTAELLNING AV PAPPERSMASSASUSPENSIONER
FI833648A (en) PROCEDURE FOR FRAMSTATION OF AV 4-METHYL-5-ALKYLTHIOMETHYLIMIDAZOLER
FI810935L (en) FRAMEWORK FOR TRAVELING OF SUBSTANCES TRIARYLTIAZOLE-FOERENINGAR
FI820054L (en) FREQUENCY FRAMING FOR FRUCTION
FI831914A0 (en) FRAMEWORK FOR THE FRAMEWORK OF PYRIMIDINONERS AND THEIR SYRAADDITIONSSALT
FI832508A0 (en) FRAMEWORK FOR MAINTENANCE OF MAINNESS-GAMMA-INTERFERENCE
FI800481A (en) FRAMEWORK FOR THE SUBSTANCES OF ACYLPIPERIDINER
FI810016L (en) FORM FRAMSTAELLNING AV (2-AMINOTIAZOL-4-YL) ACETYXYRAHYDROCHLORIDE
FI811256L (en) ANORDINATION FOR FRAMSTAELLNING AV TRAESLIPMASSA
FI802445A (en) FRAMEWORK FOR FRAMSTATING AV AND JAERNFRI KROM (III) FOERENING

Legal Events

Date Code Title Description
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L26

Extension date: 20030622

MA Patent expired

Owner name: ADIR